Cytostatic activity in vitro of cycloleucine, aspartic acid and glutamic acid phosphonic analogues.
Cytostatic activity of 18 new phosphonic acid derivatives of cycloleucine, aspartic acid and glutamic acid was tested against human KB and mouse L1210s leukemia cell lines in vitro. The tests were performed according to international protocol 1.600 for screening of chemical agents against tissue culture system. Four of the tested compounds revealed their cytostatic activity at the dose 10 micrograms/ml.
D000596:Amino Acids / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002478:Cells, Cultured; D055598:Chemical Phenomena; D002621:Chemistry; D003515:Cycloleucine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005971:Glutamates / Q000627:therapeutic use*; D006801:Humans; D066298:In Vitro Techniques; D007939:Leukemia L1210 / Q000473:pathology; D051379:Mice; D009303:Nasopharyngeal Neoplasms / Q000473:pathology; D009305:Nasopharynx / Q000473:pathology
D000596:Amino Acids; D000970:Antineoplastic Agents; D005971:Glutamates; D003515:Cycloleucine; D001224:Aspartic Acid